Given Imaging’s Japan Reimbursement Drives 45% Stock Gain In 2nd Quarter
This article was originally published in The Gray Sheet
Executive Summary
Given Imaging's receipt of Japanese marketing and reimbursement clearance for its flagship PillCam SB ingestible video capsule endoscope system helped propel a 45.5% stock price jump in the second quarter